Actively Recruiting
Diagnostic Interest of Bone Tomoscintigraphy in the Search for Cervical Pseudarthrosis
Led by Ramsay Générale de Santé · Updated on 2025-08-24
100
Participants Needed
1
Research Sites
112 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cervical pseudarthrosis is a classic complication and a challenge for challenge for spine surgeons. The rate of pseudarthrosis can range from 3 to 15%, and depend greatly on the patient, the approach the number of levels operated on. Although some patients remain asymptomatic, most require revision surgery instability, cervical or radicular pain. Diagnosis of cervical pseudarthrosis remains difficult. The clinical presentation is non-specific, and there is no consensus on the imaging imaging. Radiographic evaluation lacks sensitivity. The dynamic images require prior calibration and anatomical landmarks difficult to visualize. Angle measurement lacks reproducibility and sensitivity. CT scans, currently considered the gold standard as the gold standard, provides valuable morphological data but does not provide information on the functional nature of bone bridges the functional nature of bone bridges and apparent consolidation, particularly incomplete. At the same time, functional imaging using bone scintigraphy has been historically limited by lack of spatial resolution, absence of anatomical and radiation attenuation for deep structures.The advent of hybrid imaging makes it possible to these limitations. Recently, the 6 to 16 scanners fitted to gamma cameras enable a detailed study correlations between functional and anatomical data. Interpretation criteria remain unestablished, however, and only one study reports the use of hydric bone imaging in the study of cervical pseudarthrosis. All patients were positive on scintigraphy. However, given the absence of "healthy" patients and the small number of patients the diagnostic value of bone scintigraphy in this indication.
CONDITIONS
Official Title
Diagnostic Interest of Bone Tomoscintigraphy in the Search for Cervical Pseudarthrosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 21 years of age
- Patients who have undergone cervical arthrodesis and are being treated at Clinique de la Sauvegarde or Clinique Convert
- Patients with a Neck Disability Index (NDI) clinical score greater than 5 at 1 year
- Patient affiliated to or beneficiary of a Social Security scheme as defined by law
You will not qualify if you...
- Patients whose clinical condition requires rapid treatment that cannot wait for examinations
- Pregnancy and breastfeeding
- Protected persons under curatorship, guardianship, or safeguard of justice
- History of hypersensitivity to sodium oxidronate or any of its constituents
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinique Convert ( INA)
Bourg-en-Bresse, France, 01000
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here